相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PI3K(p110α) Protects Against Myocardial Infarction-Induced Heart Failure Identification of PI3K-Regulated miRNA and mRNA
Ruby C. Y. Lin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Ethnic Differences in Physiological Cardiac Adaptation to Intense Physical Exercise in Highly Trained Female Athletes
J. Rawlins et al.
CIRCULATION (2010)
Deletion of Akt1 causes heart defects and abnormal cardiomyocyte proliferation
Zai Chang et al.
DEVELOPMENTAL BIOLOGY (2010)
Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy
Karina Huynh et al.
DIABETES (2010)
Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis
Edward J. Davies et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Clinical Significance of Endogenous Vasoactive Neurohormones in Chronic Systolic Heart Failure
W. H. Wilson Tang et al.
JOURNAL OF CARDIAC FAILURE (2010)
Influence of sex on the Athlete's Heart in trained cyclists
Thomas Rowland et al.
JOURNAL OF SCIENCE AND MEDICINE IN SPORT (2010)
Long-Term Clinical Consequences of Intense, Uninterrupted Endurance Training in Olympic Athletes
Antonio Pelliccia et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Adrenergic Signaling Polymorphisms and Their Impact on Cardiovascular Disease
Gerald W. Dorn
PHYSIOLOGICAL REVIEWS (2010)
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
Bianca C. Bernardo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Reduced Phosphoinositide 3-Kinase (p110α) Activation Increases the Susceptibility to Atrial Fibrillation
Lynette Pretorius et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Loss of Cardiac Phosphoinositide 3-Kinase p110α Results in Contractile Dysfunction
Zhongju Lu et al.
CIRCULATION (2009)
Sudden Deaths in Young Competitive Athletes Analysis of 1866 Deaths in the United States, 1980-2006
Barry J. Maron et al.
CIRCULATION (2009)
Athlete's heart or hypertrophic cardiomyopathy?
Joerg Lauschke et al.
CLINICAL RESEARCH IN CARDIOLOGY (2009)
Role of matrix metalloproteinases and their tissue inhibitors as potential biomarkers of left ventricular remodelling in the athlete's heart
Annamaria Vianello et al.
CLINICAL SCIENCE (2009)
The protective effects of exercise and phosphoinositide 3-kinase (p110 alpha) in the failing heart
Kate L. Owen et al.
CLINICAL SCIENCE (2009)
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis
Francisco Cambronero et al.
EUROPEAN HEART JOURNAL (2009)
Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia
Anuradha Dhanasekaran et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise
A. La Gerche et al.
HEART (2008)
Ethnic differences in left ventricular remodeling in highly-trained athletes - Relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy
Sandeep Basavarajaiah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Insulin-Like Growth Factor I Receptor Signaling Is Required for Exercise-Induced Cardiac Hypertrophy
Jaetaek Kim et al.
MOLECULAR ENDOCRINOLOGY (2008)
Taking microRNAs to heart
Thomas E. Callis et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Cardiac remodelling: concentric versus eccentric hypertrophy in strength and endurance athletes
C. Mihl et al.
NETHERLANDS HEART JOURNAL (2008)
Cardiac α1-adrenergic drive in pathological remodelling
Elizabeth A. Woodcock et al.
CARDIOVASCULAR RESEARCH (2008)
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy
Ole Johan Kemi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
A conserved role for phosphatidylinositol 3-kinase but not akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy
Brian T. O'Neill et al.
CELL METABOLISM (2007)
MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets
Eva Van Rooij et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The fuzzy logic of physiological cardiac hypertrophy
Gerald W. Dorn
HYPERTENSION (2007)
Cardiac troponin increases among runners in the Boston Marathon
Elizabeth B. Fortescue et al.
ANNALS OF EMERGENCY MEDICINE (2007)
Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy
Julie R. McMullen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Endogenous inhibitors of hypertrophy in concentric versus eccentric hypertrophy
Katrien Lemmens et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Akt2 regulates cardiac metabolism and cardiomyocyte survival
Brian DeBosch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The heart of trained athletes - Cardiac remodeling and the risks of sports, including sudden death
Barry J. Maron et al.
CIRCULATION (2006)
Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program
Domenico Corrado et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Akt1 is required for physiological cardiac growth
B DeBosch et al.
CIRCULATION (2006)
Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise
J Scharhag et al.
AMERICAN HEART JOURNAL (2005)
Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy
J Luo et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
A review of the stroke volume response to upright exercise in healthy subjects
CA Vella et al.
BRITISH JOURNAL OF SPORTS MEDICINE (2005)
Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt
T Matsui et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction
Y Noji et al.
CIRCULATION JOURNAL (2004)
The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110α) pathway
JR McMullen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy
BJ Wilkins et al.
CIRCULATION RESEARCH (2004)
Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload
T Miyamoto et al.
BASIC RESEARCH IN CARDIOLOGY (2004)
Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases
BJ Maron et al.
CIRCULATION (2004)
Calcium-calcineurin signaling in the regulation of cardiac hypertrophy
BJ Wilkins et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation
J Faridi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy
JR McMullen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Myocardial collagen turnover in hypertrophic cardiomyopathy
R Lombardi et al.
CIRCULATION (2003)
Sudden death in young athletes
BJ Maron
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure
P Altieri et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
The α1A/C- and α1B-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse
TD O'Connell et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Progression from compensated hypertrophy to failure in the pressure-overloaded human heart -: Structural deterioration and compensatory mechanisms
S Hein et al.
CIRCULATION (2003)
Does the human heart fatigue subsequent to prolonged exercise?
E Dawson et al.
SPORTS MEDICINE (2003)
Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death
OF Bueno et al.
CIRCULATION RESEARCH (2002)
Release of preformed Ang II from myocytes mediates angiotensinogen and ET-1 gene overexpression in vivo via AT1 receptor
PA Modesti et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice
G Condorelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Akt/Protein kinase B promotes organ growth in transgenic mice
T Shioi et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Hypertrophic cardiomyopathy - A systematic review
BJ Maron
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning
A Pelliccia et al.
CIRCULATION (2002)
Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor
WG Thomas et al.
CIRCULATION RESEARCH (2002)
Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes
GGN Serneri et al.
CIRCULATION RESEARCH (2001)
Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes
N Wettschureck et al.
NATURE MEDICINE (2001)
Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy
RL Nicol et al.
EMBO JOURNAL (2001)
Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function
GGN Serneri et al.
CIRCULATION RESEARCH (2001)
Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy
DS Lim et al.
CIRCULATION (2001)
The role of angiotensin II, endothelin-1 and transforming growth factor-β as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy
AJET van Wamel et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
The conserved phosphoinositide 3-kinase pathway determines heart size in mice
T Shioi et al.
EMBO JOURNAL (2000)
Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling
JN Cohn et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart
Y Fujio et al.
CIRCULATION (2000)
Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
T Taigen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The athlete's heart - A meta-analysis of cardiac structure and function
BM Pluim et al.
CIRCULATION (2000)
Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy
AJ Marian
LANCET (2000)
分享论文
